Literature DB >> 17142545

Hyponatremia, hypophosphatemia, and hypouricemia in a girl with macrophage activation syndrome.

Kazuki Yamazawa1, Kazuki Kodo, Jun Maeda, Sayu Omori, Mariko Hida, Tetsuya Mori, Midori Awazu.   

Abstract

Macrophage activation syndrome, a life-threatening complication of rheumatic disorders, is accompanied by the overproduction of cytokines. We describe a girl with macrophage activation syndrome complicating systemic-onset juvenile arthritis who developed hyponatremia, hypophosphatemia, and hypouricemia associated with a high level of serum tumor necrosis factor alpha. Renal proximal tubule dysfunction was considered to be the cause, which may be attributable to tumor necrosis factor alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142545     DOI: 10.1542/peds.2006-1127

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.

Authors:  Tellen D Bennett; Mark Fluchel; Aimee O Hersh; Kristen N Hayward; Adam L Hersh; Thomas V Brogan; Rajendu Srivastava; Bryan L Stone; E Kent Korgenski; Michael B Mundorff; T Charles Casper; Susan L Bratton
Journal:  Arthritis Rheum       Date:  2012-12

2.  Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit.

Authors:  Anneke Bech; Michiel Blans; Darryl Telting; Hans de Boer
Journal:  Intensive Care Med       Date:  2013-07-20       Impact factor: 17.440

3.  Histiocytic glomerulopathy associated with macrophage activation syndrome.

Authors:  Alfonso Eirin; Maria V Irazabal; Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin Kidney J       Date:  2015-02-17

4.  Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.

Authors:  Raheleh Assari; Vahid Ziaee; Arash Mirmohammadsadeghi; Mohammad-Hassan Moradinejad
Journal:  Dis Markers       Date:  2015-04-30       Impact factor: 3.434

5.  Development of Severe Hyponatremia due to Salt-Losing Nephropathy after Esophagectomy for Esophageal Cancer.

Authors:  Katsunobu Yoshioka; Minako Nishio; Soichi Sano; Katsunobu Sakurai; Keiko Yamagami; Yoshito Yamashita
Journal:  Case Rep Med       Date:  2009-10-28

6.  Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.

Authors:  Vladislav Vukomanovic; Stasa Krasic; Sergej Prijic; Sanja Ninic; Sasa Popovic; Gordana Petrovic; Snezana Ristic; Radoje Simic; Ivana Cerovic; Dejan Nesic
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.